Journal profile · ONCOLOGY
Oncology in Clinical Practice
ISSN 2450-1654 · eISSN 2450-6478 · VM Media sp. z o.o. VM Group sp.k. · Poland
Oncology in Clinical Practice: CAS Zone 4 · Medicine (2025 upgraded edition); diamond open access (no APC); no APC; review about 15 weeks (community reports); 102 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Oncology in Clinical Practice is published by VM Media sp. z o.o. VM Group sp.k. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Lung Cancer Treatments and Mutations, Cancer Treatment and Pharmacology and PI3K/AKT/mTOR signaling in cancer, together about 24.9% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Oncology in Clinical Practice (OCP) is a peer-reviewed, Open Access journal that features papers on various types of neoplastic disease, including diagnosis, therapy (predominantly systemic treatment but also radiotherapy), molecular biology of cancer, pathology and also psychooncology. The Journal publishes research articles, reviews, case studies, information on conferences, literature reviews and letters to the Editor. OCP is published on a bimonthly basis in both electronic and print versions with first being the primary one. OCP is a reading recommended for all those with an interest in the treatment of cancer.
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY
Editor-in-chief Maciej KrzakowskiPublisher website
Editorial board by country: none in mainland China; most named Poland 47, Italy 3, United States 2, United Kingdom 1, Netherlands 1 (56 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Lung Cancer Treatments and MutationsMedicine10.7%
- Cancer Treatment and PharmacologyMedicine7.8%
- PI3K/AKT/mTOR signaling in cancerBiochemistry, Genetics and Molecular Biology6.3%
- Cancer Immunotherapy and BiomarkersMedicine6.1%
- Neuroendocrine Tumor Research AdvancesMedicine5.6%
- Lung Cancer Research StudiesMedicine5.6%
- Multiple and Secondary Primary CancersMedicine4.9%
- HER2/EGFR in Cancer ResearchMedicine4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbaseCASPublisher website
Other: Google Scholar, EBSCO, CNKI, Crossref, Arianta, Biochemistry and Biophysics Citation Index, CNKI (China National Knowledge Index), Index Copernicus, Index Scholar, Polish Medical Library (GBL), Polish Scientific Bibliography (PBN), Polindex, SJR (Scimago Journal & Country Rank), Urlichs' Periodicals Directory
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1LetPub ·
- SJR 2026-06
- 0.18LetPub ·
- SNIP 2026-06
- 0.21LetPub ·
- h-index
- 13OpenAlex ·
- i10-index
- 18OpenAlex ·
- 2-year mean citedness
- 0.45OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 99.6%LetPub ·
Volume
- Articles per year
- 82LetPub ·
Articles by year OpenAlex count · 930 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 49 | 49 | 1 |
| 2025 | 102 | 102 | 35 |
| 2024 | 71 | 71 | 63 |
| 2023 | 81 | 81 | 83 |
| 2022 | 61 | 61 | 128 |
| 2021 | 51 | 51 | 57 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
Too few articlesOnly 1 articles from the last 24 months carry both submission and acceptance dates, too few for a median
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 15 weeksLetPub ·
- Submission to publication (journal-reported)
- about 13 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC-ND | |
| LetPub | No APC | No | — |
Other charges and waivers (author guidelines)
- Other fees
- No other fees
- Submission fee
- No submission fee
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 3
- Reference style
- Vancouver
- First submission
- Free format: the journal's layout is not required
- Cover letter
- Required
Article types accepted6, with length limits
- case reportvignettes, publication of standard size case reports (with manuscripts not exceeding 2000 words) may be exceptionally possible if they present rare and atymain text ≤ 2,000 words
- clinical vignettesclinical vignettes — 700 wordsLength not stated
- letterletters — 1000 wordsLength not stated
- original articled space for a specific type of article: original article — 3000 words, review article — 6 000 words, letters — 1000 words (not inmain text ≤ 3,000 words
- reviewreview article — 6 000 wordsLength not stated
- review articlearticle: original article — 3000 words, review article — 6 000 words, letters — 1000 words (not including abstract, tables and references), clinical vmain text ≤ 1,000 words
Policy excerpts from the journal's websitePublication ethics, License & copyright, Open access, Peer review, Self-archiving
- Publication ethics Publication ethics and malpractice statement
Adheres to COPE principles Model summary
The Editor is responsible for everything published in the journal. The Editor takes all reasonable steps to ensure the quality of the material published. The Editor’s decision to accept or reject a paper for publication is based only on the paper’s importance, originality, clarity and the study’s relevance to the remit of the journal. The description of peer review process is published and clarifi…
Source ↗Publisher website ·- License & copyright Copyright Notice
In sending the manuscript the author(s) confirm(s) that (s)he has (they have) not previously submitted it to another journal (expect for abstracts of no more than 400 words) or published it elsewhere. The author(s) also agree(s), if and when the manuscript is accepted for publication, to automatic and free transfer of copyright to the Publisher allowing for the publication and distribution of the …
Source ↗Publisher website ·- Open access Open Access Policy
All articles published in “Oncology in Clinical Practice” are available in gold open access formula and are published under Creative Common Attribution-Non Commercial-No Derivatives 4.0, International Licence (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them c…
Source ↗Publisher website ·- Peer review Peer Review Process
Follows ICMJE editorial recommendations Model summary
Peer Review Process The Journal is committed to prompt evaluation and publication of submitted articles. All manuscripts together with supplementary files (if applicable) should be submitted online via the journal web page. The submission and review process is fully electronic and submissions by e-mail or postal mail will not be accepted. Please follow the manuscript preparation directions present…
Source ↗Publisher website ·- Self-archiving Self-archiving Policy
Via Medica (Publisher) self-archiving policy establishes that authors can archive only accepted manuscripts, including the final PDF version and/or early publication of aricles in any repository. In details, the author may only post their version provided acknowledgment is given to the original source of publication, and a link is inserted to the published article on Via Medica (Publisher) website…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- VM Media sp. z o.o. VM Group sp.k.
- Country or region
- Poland
- Language
- English
- ISSN
- 2450-1654
- Electronic ISSN
- 2450-6478
- Society / sponsor
- Polish Society of Clinical Oncology
- Latest issue on the website
- Volume 22 (2026)
- Official links
FAQ
Frequently asked questions about Oncology in Clinical Practice
What CAS zone is Oncology in Clinical Practice in?
In the 2025 upgraded edition of the CAS Journal Ranking, Oncology in Clinical Practice is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Oncology in Clinical Practice?
Authors report an average review time of about 15 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Oncology in Clinical Practice?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 3; Reference style: Vancouver; First submission: Free format: the journal's layout is not required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Oncology in Clinical Practice based?
Of the 56 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Poland (47), Italy (3) and United States (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Oncology in Clinical Practice?
According to LetPub and DOAJ records, Oncology in Clinical Practice is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Embase and CAS; that list has not been checked against each database.
Is Oncology in Clinical Practice open access, and what is the APC?
Oncology in Clinical Practice is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .